1	The	DT	5	det
2	Food	NNP	5	nn
3	and	CC	2	cc
4	Drug	NNP	2	conj
5	Administration	NNP	6	nsubj
6	said	VBD	0	root
7	American	NNP	9	nn
8	Home	NNP	9	nn
9	Products	NNP	10	nn
10	Corp.	NNP	11	nsubj
11	agreed	VBD	6	ccomp
12	to	TO	13	aux
13	recall	VB	11	xcomp
14	certain	JJ	16	amod
15	generic	JJ	16	amod
16	drugs	NNS	13	dobj
17	that	WDT	19	nsubjpass
18	were	VBD	19	auxpass
19	produced	VBN	16	rcmod
20	by	IN	19	prep
21	its	PRP$	24	poss
22	Quantum	NNP	23	nn
23	Pharmics	NNP	24	nn
24	unit	NN	20	pobj
25	in	IN	24	prep
26	Amityville	NNP	25	pobj
27	,	,	26	punct
28	N.Y	NNP	26	appos
29	.	.	6	punct

1	Quantum	NNP	2	nsubj
2	stopped	VBD	0	root
3	shipping	VBG	2	dep
4	the	DT	5	det
5	drugs	NNS	3	dobj
6	last	JJ	7	amod
7	month	NN	3	tmod
8	,	,	3	punct
9	following	VBG	3	prep
10	a	DT	12	det
11	federal	JJ	12	amod
12	investigation	NN	9	pobj
13	regarding	VBG	12	partmod
14	information	NN	13	dobj
15	the	DT	16	det
16	company	NN	17	nsubj
17	supplied	VBD	14	rcmod
18	to	TO	19	aux
19	obtain	VB	17	xcomp
20	three	CD	22	num
21	drug	NN	22	nn
22	approvals	NNS	19	dobj
23	.	.	2	punct

1	The	DT	2	det
2	FDA	NNP	3	nsubj
3	requested	VBD	0	root
4	the	DT	5	det
5	recall	NN	3	dobj
6	of	IN	5	prep
7	Quantum	NNP	10	poss
8	's	POS	7	possessive
9	mioxidil	NN	10	nn
10	tablets	NNS	6	pobj
11	,	,	10	punct
12	chlorazepate	NN	13	nn
13	dipotassium	NN	14	nn
14	tablets	NNS	10	conj
15	and	CC	10	cc
16	meclofenamate	NN	17	nn
17	sodium	NN	18	nn
18	capsules	NNS	10	conj
19	because	IN	41	mark
20	,	,	22	punct
21	it	PRP	22	nsubj
22	said	VBD	41	dep
23	,	,	22	punct
24	the	DT	25	det
25	size	NN	41	nsubjpass
26	of	IN	25	prep
27	the	DT	29	det
28	production	NN	29	nn
29	runs	NNS	26	pobj
30	submitted	VBN	29	partmod
31	for	IN	30	prep
32	testing	NN	31	pobj
33	to	TO	34	aux
34	gain	VB	30	xcomp
35	FDA	NNP	36	nn
36	approval	NN	34	dobj
37	was	VBD	41	auxpass
38	in	IN	41	prep
39	each	DT	40	det
40	case	NN	38	pobj
41	misrepresented	VBD	3	advcl
42	as	IN	41	prep
43	much	RB	44	advmod
44	larger	JJR	42	pobj
45	than	IN	48	mark
46	it	PRP	48	nsubj
47	actually	RB	48	advmod
48	was	VBD	44	dep
49	.	.	3	punct

1	American	NNP	3	nn
2	Home	NNP	3	nn
3	Products	NNP	10	nsubj
4	,	,	3	punct
5	based	VBN	3	partmod
6	in	IN	5	prep
7	New	NNP	8	nn
8	York	NNP	6	pobj
9	,	,	3	punct
10	agreed	VBD	0	root
11	to	TO	12	aux
12	recall	VB	10	xcomp
13	four	CD	15	num
14	other	JJ	15	amod
15	products	NNS	12	dobj
16	,	,	15	punct
17	trazadone	NN	15	appos
18	,	,	17	punct
19	doxepin	NN	17	conj
20	,	,	17	punct
21	diazepam	NN	17	conj
22	and	CC	17	cc
23	lorazapam	NN	17	conj
24	,	,	12	punct
25	because	IN	26	mwe
26	of	IN	12	prep
27	concerns	NNS	26	pobj
28	about	IN	27	prep
29	data	NNS	28	pobj
30	submitted	VBN	29	partmod
31	in	IN	30	prep
32	their	PRP$	35	poss
33	original	JJ	35	amod
34	approval	NN	35	nn
35	applications	NNS	31	pobj
36	before	IN	30	prep
37	the	DT	38	det
38	FDA	NNP	36	pobj
39	.	.	10	punct

1	No	DT	3	det
2	safety	NN	3	nn
3	problems	NNS	8	nsubjpass
4	with	IN	3	prep
5	the	DT	6	det
6	products	NNS	4	pobj
7	are	VBP	8	auxpass
8	known	VBN	12	ccomp
9	,	,	12	punct
10	the	DT	11	det
11	FDA	NNP	12	nsubj
12	said	VBD	0	root
13	.	.	12	punct

1	An	DT	3	det
2	FDA	NNP	3	nn
3	spokesperson	NN	4	nsubj
4	said	VBD	0	root
5	the	DT	6	det
6	drugs	NNS	9	nsubj
7	are	VBP	9	cop
8	still	RB	9	advmod
9	available	JJ	4	ccomp
10	under	IN	9	prep
11	other	JJ	13	amod
12	brand	NN	13	nn
13	names	NNS	10	pobj
14	.	.	4	punct

1	Last	JJ	2	amod
2	month	NN	7	tmod
3	,	,	7	punct
4	American	NNP	6	nn
5	Home	NNP	6	nn
6	Products	NNP	7	nsubj
7	said	VBD	0	root
8	it	PRP	10	nsubj
9	was	VBD	10	aux
10	suspending	VBG	7	ccomp
11	production	NN	10	dobj
12	and	CC	11	cc
13	distribution	NN	11	conj
14	of	IN	11	prep
15	all	DT	16	det
16	21	CD	14	pobj
17	of	IN	16	prep
18	Quantum	NNP	22	poss
19	's	POS	18	possessive
20	generic	JJ	21	amod
21	drug	NN	22	nn
22	products	NNS	17	pobj
23	pending	VBG	10	prep
24	the	DT	25	det
25	completion	NN	23	pobj
26	of	IN	25	prep
27	an	DT	30	det
28	exhaustive	JJ	30	amod
29	internal	JJ	30	amod
30	audit	NN	26	pobj
31	.	.	7	punct

1	It	PRP	4	nsubj
2	also	RB	4	advmod
3	temporarily	RB	4	advmod
4	closed	VBD	0	root
5	Quantum	NNP	4	dobj
6	,	,	4	punct
7	because	IN	8	mwe
8	of	IN	4	prep
9	the	DT	11	det
10	internal	JJ	11	amod
11	investigation	NN	8	pobj
12	,	,	11	punct
13	as	RB	11	advmod
14	well	RB	11	advmod
15	as	IN	11	amod
16	the	DT	17	det
17	FDA	NNP	20	poss
18	's	POS	17	possessive
19	ongoing	JJ	20	amod
20	inquiry	NN	11	dep
21	.	.	4	punct

1	In	IN	12	prep
2	New	NNP	3	nn
3	York	NNP	5	nn
4	Stock	NNP	5	nn
5	Exchange	NNP	7	nn
6	composite	JJ	7	amod
7	trading	NN	1	pobj
8	,	,	12	punct
9	American	NNP	11	nn
10	Home	NNP	11	nn
11	Products	NNP	12	nsubj
12	rose	VBD	0	root
13	75	CD	14	num
14	cents	NNS	12	dobj
15	to	TO	12	prep
16	$	$	15	pobj
17	105	CD	16	num
18	on	IN	12	prep
19	Friday	NNP	18	pobj
20	.	.	12	punct


